Altor BioScience's Series E Round

Altor BioScience raised a round of funding on March 14, 2013. Investors include Sanderling Ventures.

Altor BioScience is a biopharmaceutical company engaged in the discovery, development and commercialization of high-value, targeted immunotherapeutic agents for the treatment of cancer, viral infectio…

Articles about Altor BioScience's Series E Round: